ChiCTR-TRC-14004478
正在进行
/
/
/
2014-04-10
/
/
Elective surgery with potential massive blood loss requiring blood transfusion
圍手術期輸血指征評分（Peri-Operative Transfusion Trigger Score, POTTS）安全性與有效性的多中心，隨機，對照臨床研究
圍手術期輸血指征評分（Peri-Operative Transfusion Trigger Score, POTTS）安全性與有效性的多中心，隨機，對照臨床研究
圍手術期輸血指征評分（Peri-Operative Transfusion Trigger Score, POTTS）安全性與有效性
随机平行对照
其它
Randomized
pen label
Prince of Wales Hospital, Shatin, Hong Kong
/
20
/
2014-02-20
1990-01-01
/
1. Age older than 14 weeks old; 2. Live in an area of altitude shorter than 2500 m most of the time; 3. Estimated intraoperative blood loss more than 1000ml, or more than 20% of total blood volume.；
登录查看1. Emergency surgery; 2. Patients with physical status of ASA class V or above; 3. Patients with known severe haematological disorders; 4. Patients with known haemaglobinopathy; 5. Acute hypervolemic haemodilution is planned; 6. Patients with known metastatic cancer or more than one neoplasm concurrently; 7. Other conditions that may preclude the patients from the study, such as language barrier, psychiatric disorders, unable to attend research center for follow up; 8. Patients who enrolled to another research study or are taking experimental medication in last 3 months prior to this study; 9. Not suitable for the study, after assessment by the investigators.；
登录查看Prince of Wales Hospital, Shatin, Hong Kong
/
动脉网-最新2024-11-25
BioArtMED2024-11-25
求实药社2024-11-25
一度医药2024-11-25
肝脏时间2024-11-25
细胞与基因治疗领域2024-11-25
细胞与基因治疗领域2024-11-25
加科思2024-11-25
BioArt2024-11-25
爱科百发2024-11-25
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
